Glycemic instability estimated by 1,5-anhydroglucitol persists even after normalization of A1C by treatment in patients with type 2 diabetes

被引：0
|
作者：
Kawasaki, Takahiro
Ichiyanagi, Kaoru
Yamanouchi, Toshikazu
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A105 / A106
页数：2
相关论文
共 50 条
  • [31] 1,5-ANHYDROGLUCITOL IN DIABETES: ITS ROLE IN DIAGNOSTICS, SCREENING, GLYCEMIC STATUS ASSESSMENT, AND THE PREDICTION OF COMPLICATIONS
    Klimontov, Vadim V.
    Dashkin, Maxim, V
    DIABETES MELLITUS, 2020, 23 (03): : 250 - 259
  • [32] Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus
    Ouchi, Motoshi
    Oba, Kenzo
    Aoyama, Junya
    Watanabe, Kentaro
    Ishii, Kazuhito
    Yano, Hiroyuki
    Motoyama, Masayuki
    Sekimizu, Ken-ichi
    Matsumura, Noriaki
    Igari, Yoshimasa
    Suzuki, Tatsuya
    Nakano, Hiroshi
    CLINICAL BIOCHEMISTRY, 2013, 46 (15) : 1436 - 1441
  • [33] Exenatide improves postprandial glucose (PPG) control in patients with type 2 diabetes, as measured by 1,5-anhydroglucitol (GlycoMark)
    Kendall, David
    Button, Eric
    Blase, Erich
    Conlin, Therese
    Schroeder, Brock
    Guan, Xuesong
    Holcombe, John
    Wintle, Matthew
    Kim, Dennis
    Okerson, Ted
    Bhole, Deepak
    DIABETES, 2007, 56 : A560 - A560
  • [34] Increased 1,5-Anhydroglucitol Predicts Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes Treated with Short-Term Intensive Insulin Therapy
    Liu, Liehua
    Wan, Xuesi
    Liu, Juan
    Huang, Zhimin
    Cao, Xiaopei
    Li, Yanbing
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (09) : 756 - +
  • [35] COMPARISON OF 1,5-ANHYDROGLUCITOL, HBA1C, AND FRUCTOSAMINE FOR DETECTION OF DIABETES-MELLITUS
    YAMANOUCHI, T
    AKANUMA, Y
    TOYOTA, T
    KUZUYA, T
    KAWAI, T
    KAWAZU, S
    YOSHIOKA, S
    KANAZAWA, Y
    OHTA, M
    BABA, S
    KOSAKA, K
    DIABETES, 1991, 40 (01) : 52 - 57
  • [36] 1,5-Anhydroglucitol Correlates with Postprandial Glucose in Subjects with Type 1 Diabetes Irrespective of HbA1c Responder Status
    Heller, Simon R.
    Bowering, Keith
    Raskin, Philip
    Liebl, Andreas
    Buchholtz, Kristine
    Bretler, Ditte-Marie
    Pieber, Thomas R.
    DIABETES, 2017, 66 : A260 - A261
  • [37] 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes
    Won, Jong Chul
    Park, Cheol-Young
    Park, Hyo-Soon
    Kim, Ji Hoom
    Choi, Eun Sook
    Rhee, Eun Jung
    Lee, Won Young
    Oh, Ki Won
    Kim, Sun Woo
    Park, Sung Woo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 84 (01) : 51 - 57
  • [38] 1,5-anhydroglucitol correlates with postprandial glucose in subjects with type 1 diabetes irrespective of HbA1c responder status
    Heller, S.
    Bowering, K.
    Raskin, P.
    Liebl, A.
    Buchholtz, K.
    Demissie, M.
    Pieber, T. R.
    DIABETOLOGIA, 2017, 60 : S312 - S313
  • [39] Screening for Cystic Fibrosis-Related Diabetes and Prediabetes-Evaluating 1,5-Anhydroglucitol, Fructosamine, Glycated Albumin, and Hemoglobin A1c
    Tommerdahl, Kalie L.
    Brinton, John T.
    Vigers, Tim B.
    Nadeau, Kristen J.
    Zeitler, Phil
    Chan, Christine L.
    DIABETES, 2018, 67
  • [40] 1,5-ANHYDROGLUCITOL CORRELATES WITH POSTPRANDIAL GLUCOSE IN SUBJECTS WITH TYPE 1 DIABETES IRRESPECTIVE OF HBA1C RESPONDER STATUS
    Heller, S.
    Bowering, K.
    Raskin, P.
    Liebl, A.
    Buchholtz, K.
    Demissie, M.
    Pieber, T. R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A31 - A32
12345